"L'Institut Bergonié est un établissement de santé privé d'intérêt collectif. Il est le centre de lutte contre le cancer de la Nouvelle-Aquitaine"

During the past decade, Institut Bergonié conducted 400 clinical trials. In the 10-year time frame, 400 clinical trials started and 85 clinical trials were completed, i.e. on average, 21.3% percent of trials that started reached the finish line to date. In the past 5 years, 185 clinical trials started and 71 clinical trials were completed. i.e. 38.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Bergonié" #1 sponsor was "Institut Bergonié" with 93 trials, followed by "UNICANCER" with 74 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 49 trials sponsored, "Centre Leon Berard" with 39 trials sponsored and "ARCAGY/ GINECO GROUP" with 39 trials sponsored. Other sponsors include 388 different institutions and companies that sponsored additional 150 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Bergonié" #1 collaborator was "National Cancer Institute, France" with 24 trials as a collaborator, "AstraZeneca" with 21 trials as a collaborator, "Merck Sharp & Dohme LLC" with 18 trials as a collaborator, "Roche Pharma AG" with 12 trials as a collaborator and "Ministry of Health, France" with 11 trials as a collaborator. Other collaborators include 446 different institutions and companies that were collaborators in the rest 262 trials.

According to Clinical.Site data, the most researched conditions in "Institut Bergonié" are "Breast Cancer" (71 trials), "Prostate Cancer" (29 trials), "Ovarian Cancer" (26 trials), "Cancer" (21 trials) and "Colorectal Cancer" (20 trials). Many other conditions were trialed in "Institut Bergonié" in a lesser frequency.

Most popular intervention types in "Institut Bergonié" are "Drug" (479 trials), "Other" (88 trials), "Procedure" (83 trials), "Radiation" (65 trials) and "Biological" (41 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Paclitaxel" (23 trials), "radiation therapy" (21 trials), "Pembrolizumab" (19 trials) and "fluorouracil" (19 trials). Other intervention names were less common.

The vast majority of trials in "Institut Bergonié" are 466 trials for "All" genders, 154 trials for "Female" genders and 46 trials for "Male" genders.

Currently, there are 301 active trials in "Institut Bergonié". 5 are not yet recruiting, 170 are recruiting, 125 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 269 completed trials in Institut Bergonié, 3 suspended trials, and 59 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Bergonié, 100 "Phase 1" clinical trials were conducted, 256 "Phase 2" clinical trials and 193 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 91 trials that are defined as “Not Applicable".

Institut Bergonié has several departments that took part in Clinical trials: "Institut Bergonie; Oncologie" - 23 trials, "Institut Bergonie; Hematologie Oncologie" - 3 trials